About Carroucell
Carroucell is a Healthcare company based in Grenoble (France) founded in 2016 by Tarek Fathallah. Microcarriers for bioreactor cell culture are provided by Carroucell. Carroucell has raised $1.49 million across 1 funding round from investors including Bpifrance, Novalis Biotech and CA des Savoie. Its chief executive, as recorded, is Takis Breyiannis. Carroucell offers products and services including FlexiGrow Solution. Its focus areas include Life Sciences, Life Sciences Platforms and Tools, Instruments and Cell Biology.
Company details
Carroucell was founded in 2016 and is based in Grenoble, France. Operations are conducted in the biotechnology sector, where microcarriers for cell culture in bioreactors are supplied. A technological platform has been established, featuring flat-shaped microcarriers made from glass xenofree composition. These tools support scalable cell expansion processes for research and production applications. Leadership includes founder Tarek Fathallah and CEO Takis Breyiannis.
- Headquarters Grenoble, France
- Founders Tarek Fathallah
- SectorsHealthcare
- Email••••••••
- Website carroucell.com
- Social LinkedIn YouTube
- Total Equity Funding$1.49M (USD)
in 1 rounds
- Latest Funding Round$1.49M (USD), Series A
Sep 2022
- InvestorsBpifrance
& 2 more
Products & Services of Carroucell
Carroucell offers a comprehensive portfolio of products and services, including FlexiGrow Solution.
Microcarriers for cost-effective cell amplification in gene therapy applications.
Apps and channels of Carroucell
its YouTube channel Carroucell has 7 subscribers and 10 videos.
Videos from Carroucell
The most watched videos on Carroucell's YouTube channel, Carroucell (7 subscribers). Click a video to play it here.
More on Carroucell.
Funding Insights of Carroucell
Carroucell has successfully raised a total of $1.49M through 1 strategic funding round. The most recent funding activity was a Series A round of $1.49 million completed in September 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $1.49M
- Total Rounds 1
- Last Round Series A — $1.49M
- First Round $1.49M
(Sep 2022)
- Investors Count 3
All 1 funding rounds of Carroucell with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Sep 2022 | $1.49M | Series A | – | Novalis Biotech |
3 investors in total: 3 institutional.
Investors in Carroucell
Carroucell has secured backing from 3 investors, including venture fund and institutional investors. Prominent investors backing the company include Bpifrance, Novalis Biotech and CA des Savoie.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Early-stage venture capital investment is provided in life sciences. | noval.is | Ghent, Belgium | ||
Corporate consultancy, advisory, and funding services are provided to businesses. | 2012 | bpifrance.com | Maisons Alfort, France | |
Offers banking, savings, insurance, loans, and financial advice to individuals and businesses. | 1885 | ca-des-savoie.fr | La Motte Servolex, France |
Investor details for Carroucell
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Carroucell
3 people are tracked at Carroucell (3 in leadership).
| Name | Role | Group |
|---|---|---|
Tarek Fathallah | Founder | Leadership |
Takis Breyiannis | CEO | Leadership |
Tristan Le clainche | Chief Technology Officer | Leadership |
Complete people profiles for Carroucell
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Carroucell
2 dated milestones of Carroucell across 6 years, from founding to its latest funding, stage changes and deals.
- Founded Carroucell is founded.
- Funding First funding round of $1.5M.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Carroucell
Carroucell was founded in 2016 and raised its 1st funding round 6 years after it was founded.
Carroucell is headquartered in Grenoble, France. It is registered at Grenoble, Auvergne-rhone-alpes, France.
Takis Breyiannis is the CEO of Carroucell, as recorded in our data.
Carroucell is a funded company, having raised a total of $1.49M across 1 funding round to date. The company's 1st funding round was a Series A of $1.49M, raised on Sep 2022.
Carroucell was founded in 2016 and is based in Grenoble, France. Operations are conducted in the biotechnology sector, where microcarriers for cell culture in bioreactors are supplied. A technological platform has been established, featuring flat-shaped microcarriers made from glass xenofree composition. These tools support scalable cell expansion processes for research and production applications. Leadership includes founder Tarek Fathallah and CEO Takis Breyiannis.
Carroucell offers FlexiGrow Solution.
Carroucell has 3 investors. Key investors include Bpifrance, Novalis Biotech, and CA des Savoie.